New technologies are making biological quality measurable at the soil, plant and animal level. That quality can be linked to nutrition, verified and carried through the supply chain.
Once buyers can procure against biological quality, demand for health becomes an economic signal back to agriculture. This allows more value to accrue to nutrition and biological outcomes rather than only yield, uniformity and shelf life.
The wider prize is healthspan. Scaling proven health interventions could generate $12.5 trillion in additional annual global economic output by 2050, with nearly two-thirds of the opportunity coming from prevention. (McKinsey Health Institute, 2026)
We invest in the companies building the measurement, intervention, verification and data infrastructure that makes this possible. This is deeptech and physical AI applied to human longevity.